153 related articles for article (PubMed ID: 26985869)
1. Expression of MIF and c-erbB-2 in endometrial cancer.
Xiao W; Dong X; Zhao H; Han S; Nie R; Zhang X; An R
Mol Med Rep; 2016 May; 13(5):3828-34. PubMed ID: 26985869
[TBL] [Abstract][Full Text] [Related]
2. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases.
Rechichi G; Galimberti S; Signorelli M; Franzesi CT; Perego P; Valsecchi MG; Sironi S
AJR Am J Roentgenol; 2011 Jul; 197(1):256-62. PubMed ID: 21701038
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
5. Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.
Baloglu A; Bezircioglu I; Cetinkaya B; Hicyilmaz L
Ginekol Pol; 2010 Jul; 81(7):501-5. PubMed ID: 20825050
[TBL] [Abstract][Full Text] [Related]
6. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of miR-451 and its target
Mamoori A; Gopalan V; Lu CT; Chua TC; Morris DL; Smith RA; Lam AK
J Clin Pathol; 2017 Apr; 70(4):308-312. PubMed ID: 27612504
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
[TBL] [Abstract][Full Text] [Related]
10. [Methods for preoperative and intraoperative evaluation of the tumour infiltration and lymph node metastases in endometrial cancer (summarized own and foreign experience)].
Ivanov S
Akush Ginekol (Sofiia); 2010; 49(4):21-4. PubMed ID: 20734637
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic expression of c-erb-B2 in endometrial carcinomas.
Lambropoulou M; Stefanou D; Alexiadis G; Tamiolakis D; Tripsianis G; Chatzaki E; Vandoros GP; Kiziridou A; Papadopoulou E; Papadopoulos N
Onkologie; 2007 Oct; 30(10):495-500. PubMed ID: 17890888
[TBL] [Abstract][Full Text] [Related]
12. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
13. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Subbannayya T; Leal-Rojas P; Barbhuiya MA; Raja R; Renuse S; Sathe G; Pinto SM; Syed N; Nanjappa V; Patil AH; Garcia P; Sahasrabuddhe NA; Nair B; Guerrero-Preston R; Navani S; Tiwari PK; Santosh V; Sidransky D; Prasad TS; Gowda H; Roa JC; Pandey A; Chatterjee A
BMC Cancer; 2015 Nov; 15():843. PubMed ID: 26530123
[TBL] [Abstract][Full Text] [Related]
15. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
16. Expression of cellular FLICE/caspase-8 inhibitory protein is associated with malignant potential in endometrial carcinoma.
Chen HX; Liu YJ; Zhou XD; Luo RY
Int J Gynecol Cancer; 2005; 15(4):663-70. PubMed ID: 16014121
[TBL] [Abstract][Full Text] [Related]
17. The Significance of Galectin-1 and Galectin-9 Expression in Endometrial Carcinoma.
Sun XF; Dai SY
Gynecol Obstet Invest; 2020; 85(1):34-40. PubMed ID: 31487707
[TBL] [Abstract][Full Text] [Related]
18. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen.
Garzetti GG; Ciavattini A; Goteri G; Tranquilli AL; Muzzioli M; Fabris N; De Nictolis M; Romanini C
Gynecol Oncol; 1994 Oct; 55(1):111-4. PubMed ID: 7525425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
